These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Antidiabetic drugs and their potential role in treating mild cognitive impairment and Alzheimer's disease. Alagiakrishnan K; Sankaralingam S; Ghosh M; Mereu L; Senior P Discov Med; 2013 Dec; 16(90):277-86. PubMed ID: 24333407 [TBL] [Abstract][Full Text] [Related]
3. Effects of insulinic therapy on cognitive impairment in patients with Alzheimer disease and diabetes mellitus type-2. Plastino M; Fava A; Pirritano D; Cotronei P; Sacco N; Sperlì T; Spanò A; Gallo D; Mungari P; Consoli D; Bosco D J Neurol Sci; 2010 Jan; 288(1-2):112-6. PubMed ID: 19836029 [TBL] [Abstract][Full Text] [Related]
4. Pathophysiological Mechanisms Linking Type 2 Diabetes and Dementia: Review of Evidence from Clinical, Translational and Epidemiological Research. Bello-Chavolla OY; Antonio-Villa NE; Vargas-Vázquez A; Ávila-Funes JA; Aguilar-Salinas CA Curr Diabetes Rev; 2019; 15(6):456-470. PubMed ID: 30648514 [TBL] [Abstract][Full Text] [Related]
5. Metabolic links between diabetes and Alzheimer's disease. Maher PA; Schubert DR Expert Rev Neurother; 2009 May; 9(5):617-30. PubMed ID: 19402773 [TBL] [Abstract][Full Text] [Related]
6. Diabetes mellitus and Alzheimer's disease: shared pathology and treatment? Akter K; Lanza EA; Martin SA; Myronyuk N; Rua M; Raffa RB Br J Clin Pharmacol; 2011 Mar; 71(3):365-76. PubMed ID: 21284695 [TBL] [Abstract][Full Text] [Related]
7. New views and possibilities of antidiabetic drugs in treating and/or preventing mild cognitive impairment and Alzheimer's Disease. Zhong KL; Chen F; Hong H; Ke X; Lv YG; Tang SS; Zhu YB Metab Brain Dis; 2018 Aug; 33(4):1009-1018. PubMed ID: 29626315 [TBL] [Abstract][Full Text] [Related]
8. Oral antidiabetic agents: current role in type 2 diabetes mellitus. Krentz AJ; Bailey CJ Drugs; 2005; 65(3):385-411. PubMed ID: 15669880 [TBL] [Abstract][Full Text] [Related]
9. Antidiabetic Drugs in the Treatment of Alzheimer's Disease. Michailidis M; Tata DA; Moraitou D; Kavvadas D; Karachrysafi S; Papamitsou T; Vareltzis P; Papaliagkas V Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563031 [TBL] [Abstract][Full Text] [Related]
10. Antidiabetic Polypill Improves Central Pathology and Cognitive Impairment in a Mixed Model of Alzheimer's Disease and Type 2 Diabetes. Infante-Garcia C; Ramos-Rodriguez JJ; Hierro-Bujalance C; Ortegon E; Pickett E; Jackson R; Hernandez-Pacho F; Spires-Jones T; Garcia-Alloza M Mol Neurobiol; 2018 Jul; 55(7):6130-6144. PubMed ID: 29224179 [TBL] [Abstract][Full Text] [Related]
11. Cardiovascular risk of oral antidiabetic drugs: current evidence and regulatory requirements for new drugs. Panicker GK; Karnad DR; Salvi V; Kothari S J Assoc Physicians India; 2012 Jan; 60():56-61. PubMed ID: 22715547 [TBL] [Abstract][Full Text] [Related]
12. Cognitive impairment and diabetes. Dash SK Recent Pat Endocr Metab Immune Drug Discov; 2013 May; 7(2):155-65. PubMed ID: 23489242 [TBL] [Abstract][Full Text] [Related]
13. Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study. Ou HT; Chang KC; Li CY; Wu JS Cardiovasc Diabetol; 2016 Mar; 15():41. PubMed ID: 26932742 [TBL] [Abstract][Full Text] [Related]
14. Link between type 2 diabetes and Alzheimer's disease: from epidemiology to mechanism and treatment. Li X; Song D; Leng SX Clin Interv Aging; 2015; 10():549-60. PubMed ID: 25792818 [TBL] [Abstract][Full Text] [Related]
15. [Diabetes mellitus and dementia]. Tůma I Vnitr Lek; 2012 Apr; 58(4):305-8. PubMed ID: 22559805 [TBL] [Abstract][Full Text] [Related]
16. Antidiabetic drugs and stroke risk. Current evidence. Castilla-Guerra L; Fernandez-Moreno MDC; Leon-Jimenez D; Carmona-Nimo E Eur J Intern Med; 2018 Feb; 48():1-5. PubMed ID: 28939005 [TBL] [Abstract][Full Text] [Related]